Stephan Reynier
Fortuna: 38 600 $ al 31/10/2026
Fortuna: 38 600 $ al 31/10/2026
Stephan Reynier currently works at Cellectis SA, as Chief Regulatory & Compliance Officer from 2011.
Mr. Reynier also formerly worked at Gilead Sciences, Inc., as Associate Medical Affairs Director-European Region from 2002 to 2006, Voisin Consulting, Inc., as Senior Director, Takara Bio Europe AB, as Head-Project Management & Regulatory Affairs, and Ectycell SASU, as Head-Programs from 2011 to 2014.
Mr. Reynier received his graduate degree from the University of Toronto.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CELLECTIS S.A. 0,03 % | 15/02/2026 | 33.313 ( 0,03 % ) | 38 600 $ | 31/10/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CELLECTIS S.A. | Oficial de Cumplimiento | 01/04/2011 |
| Empresas | Cargo | Fin |
|---|---|---|
Ectycell SASU
Ectycell SASU BiotechnologyHealth Technology Produces and sales stem cells | Corporate Officer/Principal | 01/01/2014 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2006 |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Consejero General | - |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
Ectycell SASU
Ectycell SASU BiotechnologyHealth Technology Produces and sales stem cells | Health Technology |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.